Pacific Biosciences of California, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Pacific Biosciences of California, Inc. (PACB) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $20.65 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2024-11-12
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $20.65M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $19.48M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $19.48M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $19.55M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2024-09-30 | $20.65M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $19.48M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $19.48M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $19.55M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $18.45M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $186.32M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $184.35M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $172.09M 10-Q · filed 2023-11-03 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-03 |
| 2018-12-31 | $16.00K 10-K · filed 2020-02-28 |
| 2017-12-31 | $183.00K 10-K · filed 2020-02-28 |
| 2016-12-31 | $356.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $600.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |